Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use
2021 · World Allergy Organization Journal · 24 citations
https://doi.org/10.1016/j.waojou.2021.100600
M
Manabu Akazawa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
163
Papers
1.7K
Citations
23
h-index
47
i10-index
Manabu Akazawa is an academic researcher from Meiji Pharmaceutical University. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Pharmaceutical Practices and Patient Outcomes & Pharmacy and Medical Practices. The author has an h-index of 23, co-authored 139 publications.
ORCID: 0000-0002-4112-6035Papers by this author
worksPerceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey
2011 · BMC Health Services Research · 22 citations
https://doi.org/10.1186/1472-6963-11-306
Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis
2013 · BMC Health Services Research · 18 citations
https://doi.org/10.1186/1472-6963-13-124
Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study
2020 · Annals of Clinical Microbiology and Antimicrobials · 18 citations
https://doi.org/10.1186/s12941-020-00348-0
Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan
2022 · JAMA Network Open · 16 citations
https://doi.org/10.1001/jamanetworkopen.2021.45515
Cost-effectiveness of systematic chemotherapy for metastatic pancreatic cancer: a retrospective study using Japanese clinical data
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-024-80549-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat